Genfit(GNFT) - 2022 Q4 - Annual Report

Exhibit 99.1 GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 18, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases, today announced the filing of its 2022 Universal Registration Document with the Autorité des marchés financiers (AMF) and its Annual ...